表紙:C反応性タンパク (CRP) 試験の市場動向・市場シェア・市場規模の予測 (2021-2028年):アッセイタイプ (ELISA・免疫比濁アッセイ)・検出範囲・疾患領域 (癌・狼瘡)・エンドユーザー・地域別
市場調査レポート
商品コード
1032409

C反応性タンパク (CRP) 試験の市場動向・市場シェア・市場規模の予測 (2021-2028年):アッセイタイプ (ELISA・免疫比濁アッセイ)・検出範囲・疾患領域 (癌・狼瘡)・エンドユーザー・地域別

C-reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type (ELISA, Immunoturbidimetric Assay), By Detection Range, By Disease Area (Cancer, Lupus), By End-use, By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 149 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.72円
C反応性タンパク (CRP) 試験の市場動向・市場シェア・市場規模の予測 (2021-2028年):アッセイタイプ (ELISA・免疫比濁アッセイ)・検出範囲・疾患領域 (癌・狼瘡)・エンドユーザー・地域別
出版日: 2021年10月05日
発行: Grand View Research, Inc.
ページ情報: 英文 149 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のC反応性タンパク (CRP) 試験の市場規模は予測期間中0.3%のCAGRで推移し、2028年には56米ドルの規模に成長すると予測されています。

CRP試験の用途を探るための研究活動の活発化、官民による研究促進のための資金提供などが同市場の成長を推進しています。また、新型コロナウイルス感染症 (COVID-19) も市場に大きな影響を与えています。CRPは感染症や炎症の重症度を判定するバイオマーカーと考えられているため、CRP試験のサービスや製品に対する需要が高まっています。

当レポートでは、世界のC反応性タンパク (CRP) 試験の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、アッセイタイプ・検出範囲・疾患領域・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 市場力学
  • 市場機会の分析
  • 脅威の分析
  • 普及・成長の見通しマッピング
  • SWOT分析
  • ポーターの分析
  • COVID-19の影響

第4章 C反応性タンパク (CRP) 試験の市場推計・動向分析:アッセイタイプ別

  • 動向分析
  • 免疫比濁アッセイ
  • ELISA
    • 臨床ELISA
    • 非臨床ELISA
  • 化学発光イムノアッセイ
  • その他

第5章 C反応性タンパク (CRP) 試験の市場推計・動向分析:検出範囲別

  • 動向分析
  • 高感度CRP(hs-CRP)
  • 従来型CRP
  • 心臓CRP(cCRP)

第6章 C反応性タンパク (CRP) 試験の市場推計・動向分析:疾患領域別

  • 動向分析
  • 心血管疾患
  • 関節リウマチ
  • 炎症性腸疾患
  • 子宮内膜症
  • ループス
  • その他

第7章 C反応性タンパク (CRP) 試験の市場推計・動向分析:エンドユーザー別

  • 動向分析
  • クリニック
  • 病院
  • ラボ
  • 生活支援施設
  • 在宅医療
  • その他

第8章 C反応性タンパク (CRP) 試験の市場推計・動向分析:地域別

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 企業の分類
  • 主要企業・近年の展開・影響分析
  • 公開企業
  • 非公開企業
  • 戦略的枠組み
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Quest Diagnostics Incorporated
    • Siemens
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings(LabCorp)
    • Merck KGaA
    • Abaxis, Inc.
    • Ortho Clinical Diagnostics
    • Getein Biotech, Inc.
    • HORIBA, Ltd.
    • RandoxLaboratories Ltd.
    • BODITECH MED, INC
    • Aidian
    • EurolyserDiagnostica GmbH
    • Abcam plc
    • Bio-Techne
    • EKF Diagnostics
    • SD Biosensor, INC.
図表

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 Chances of heart diseases associated with CRP levels in blood
  • TABLE 3 Estimated new female cases of breast cancer & deaths in the U.S., 2017
  • TABLE 4 North America C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 5 North America C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 6 North America C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 7 North America C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 8 North America C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 9 North America C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 10 North America C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 11 North America C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 12 North America C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 13 North America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 14 U.S. C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 15 U.S. C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 16 U.S. C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 17 U.S. C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 18 U.S. C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 19 U.S. C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 20 U.S. C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 21 U.S. C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 22 U.S. C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 23 U.S. C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 24 Canada C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 25 Canada C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 26 Canada C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 27 Canada C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 28 Canada C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 29 Canada C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 30 Canada C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 31 Canada C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 32 Canada C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 33 Canada C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 34 Europe C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 35 Europe C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 36 Europe C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 37 Europe C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 38 Europe C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 39 Europe C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 40 Europe C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 41 Europe C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 42 Europe C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 43 Europe C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 44 Germany C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 45 Germany C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 46 Germany C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 47 Germany C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 48 Germany C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 49 Germany C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 50 Germany C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 51 Germany C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 52 Germany C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 53 Germany C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 54 U.K. C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 55 U.K. C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 56 U.K. C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 57 U.K. C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 58 U.K. C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 59 U.K. C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 60 U.K. C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 61 U.K. C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 62 U.K. C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 63 U.K. C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 64 Asia Pacific C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 65 Asia Pacific C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 66 Asia Pacific C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 67 Asia Pacific C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 68 Asia Pacific C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 69 Asia Pacific C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 70 Asia Pacific C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 71 Asia Pacific C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 72 Asia Pacific C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 73 Asia Pacific C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 74 Japan C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 75 Japan C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 76 Japan C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 77 Japan C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 78 Japan C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 79 Japan C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 80 Japan C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 81 Japan C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 82 Japan C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 83 Japan C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 84 China C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 85 China C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 86 China C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 87 China C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 88 China C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 89 China C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 90 China C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 91 China C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 92 China C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 93 China C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 94 Latin America C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 95 U.S. C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 96 Latin America C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 97 Latin America C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 98 U.S. C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 99 Latin America C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 100 Latin America C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 101 Latin America C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 102 Latin America C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 103 Latin America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 104 Brazil C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 105 Brazil C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 106 Brazil C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 107 Brazil C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 108 Brazil C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 109 Brazil C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 110 Brazil C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 111 Brazil C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 112 Brazil C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 113 Brazil C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 114 MEA C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 115 MEA C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 116 MEA C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 117 MEA C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 118 MEA C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 119 MEA C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 120 MEA C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 121 MEA C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 122 MEA C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 123 MEA C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 124 South Africa C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
  • TABLE 125 South Africa C-reactive protein testing market for ELISA, by type, 2017 - 2028 (USD Million)
  • TABLE 126 South Africa C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
  • TABLE 127 South Africa C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
  • TABLE 128 South Africa C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • TABLE 129 South Africa C-reactive protein testing market for clinics, by entity type, 2017 - 2028 (USD Million)
  • TABLE 130 South Africa C-reactive protein testing market for clinics, by setting type, 2017 - 2028 (USD Million)
  • TABLE 131 South Africa C-reactive protein testing market for hospital, by setting type, 2017 - 2028 (USD Million)
  • TABLE 132 South Africa C-reactive protein testing market for laboratories, by setting type, 2017 - 2028 (USD Million)
  • TABLE 133 South Africa C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2017 - 2028 (USD Million)
  • TABLE 134 List of key emerging companies

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Data triangulation techniques
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market summary
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market segmentation & scope
  • FIG. 11 Market driver relevance analysis (Current & future impact)
  • FIG. 12 Market restraint relevance analysis (Current & future impact)
  • FIG. 13 Technology timeline: CRP detection
  • FIG. 14 Antibiotic prescribing decisions pre- and post-CRP tests in UCC study
  • FIG. 15 Penetration & growth prospect mapping for assay type, 2020
  • FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 17 Porter's Five Forces Analysis
  • FIG. 18 Global C-reactive protein testing market: Assay type outlook key takeaways
  • FIG. 19 Global C-reactive protein testing market: Assay type movement analysis
  • FIG. 20 Global immunoturbidimetric assay market, 2017 - 2028 (USD Million)
  • FIG. 21 Global ELISA market, 2017 - 2028 (USD Million)
  • FIG. 22 Global clinical ELISA market, 2017 - 2028 (USD Million)
  • FIG. 23 Global nonclinical ELISA market, 2017 - 2028 (USD Million)
  • FIG. 24 Global chemiluminescence immunoassay market, 2017 - 2028 (USD Million)
  • FIG. 25 Global others market, 2017 - 2028 (USD Million)
  • FIG. 26 Global C-reactive protein testing market: Detection range estimates outlook key takeaways
  • FIG. 27 Global C-reactive protein testing market: Detection range movement analysis
  • FIG. 28 Global hsCRP market, 2017 - 2028 (USD Million)
  • FIG. 29 Global conventional CRP market, 2017 - 2028 (USD Million)
  • FIG. 30 Global cardiac CRP market, 2017 - 2028 (USD Million)
  • FIG. 31 Global C-reactive protein testing market: Disease area estimates outlook key takeaways
  • FIG. 32 Global C-reactive protein testing market: Disease Area movement analysis
  • FIG. 33 Global cardiovascular diseases CRP tests market, 2017 - 2028 (USD Million)
  • FIG. 34 Global cancer CRP tests market, 2017 - 2028 (USD Million)
  • FIG. 35 Global rheumatoid arthritis CRP tests market, 2017 - 2028 (USD Million)
  • FIG. 36 Global inflammatory bowel disease CRP tests market, 2017 - 2028 (USD Million)
  • FIG. 37 Global endometriosis CRP tests market, 2017 - 2028 (USD Million)
  • FIG. 38 Global lupus CRP tests market, 2017 - 2028 (USD Million)
  • FIG. 39 Global others market, 2017 - 2028 (USD Million)
  • FIG. 40 Global C-reactive protein testing market: End-use estimates outlook key takeaways
  • FIG. 41 Global C-reactive protein testing market: End-use movement analysis
  • FIG. 42 Global clinics market, 2017 - 2028 (USD Million)
  • FIG. 43 Physician office visits in the U.S., by age (Thousands)
  • FIG. 44 Global physician office market, 2017 - 2028 (USD Million)
  • FIG. 45 Global small clinic market, 2017 - 2028 (USD Million)
  • FIG. 46 Global other clinics market, 2017 - 2028 (USD Million)
  • FIG. 47 Global urban setting clinics market, 2017 - 2028 (USD Million)
  • FIG. 48 Global rural settings clinic market, 2017 - 2028 (USD Million)
  • FIG. 49 Global hospitals market, 2017 - 2028 (USD Million)
  • FIG. 50 Global urban setting hospitals market, 2017 - 2028 (USD Million)
  • FIG. 51 Global rural setting hospitals market, 2017 - 2028 (USD Million)
  • FIG. 52 Global laboratories market, 2017 - 2028 (USD Million)
  • FIG. 53 Global urban setting laboratories market, 2017 - 2028 (USD Million)
  • FIG. 54 Global rural setting laboratories market, 2017 - 2028 (USD Million)
  • FIG. 55 Global assisted living healthcare facilities market, 2017 - 2028 (USD Million)
  • FIG. 56 Global urban setting assisted living healthcare facilities market, 2017 - 2028 (USD Million)
  • FIG. 57 Global rural setting assisted living healthcare facilities market, 2017 - 2028 (USD Million)
  • FIG. 58 Global home market, 2017 - 2028 (USD Million)
  • FIG. 59 Global others market, 2017 - 2028 (USD Million)
  • FIG. 60 Regional marketplace: Key takeaway
  • FIG. 61 Global C-reactive protein testing market regional outlook, 2020 & 2028
  • FIG. 62 North America C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 63 U.S. C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 64 Canada C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 65 Europe C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 66 Germany C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 67 U.K. C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 68 Asia Pacific C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 69 Japan C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 70 China C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 71 Latin America C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 72 Brazil C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 73 Middle East & Africa C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 74 South Africa C-reactive protein testing market, 2017 - 2028 (USD Million)
  • FIG. 75 Participant categorization
  • FIG. 76 Impact analysis by key companies
  • FIG. 77 Market position analysis for public companies
  • FIG. 78 Strategy framework
目次
Product Code: GVR-2-68038-129-0

C-reactive Protein Testing Market & Trends:

The global C-reactive protein testing market size is expected to reach USD 5.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 0.3% from 2021 to 2028. The market growth can be attributed to substantial research activities to explore the applications of C-reactive protein (CRP) testing coupled with the presence of private as well as public agencies which grant funds to expedite the research proceedings in this arena.

A rise in the number of strategic deals and developments coupled with the increase in investments for R&D of C-reactive protein testing is expected to drive the market significantly. The ongoing COVID-19 pandemic has affected the CRP testing market to a great extent. As CRP is considered to be the determining biomarker for the severity of infection/inflammation, the market is witnessing increased demand for CRP testing services and products. Major operating companies such as Abbott offer supportive tools for CRP testing for SARS-CoV-2 infection.

The development of novel technologies to analyze CRP concentration is a high-impact rendering driver for market growth. The emergence and advances in nano-technological tools are expected to provide an attractive perspective in designing portable bioanalytical assays with high specificity and sensitivity, faster response time, and multiplexing capabilities for on-site accurate disease diagnosis, and monitoring. Plasmonic nanoparticles (PNPs) is a tool that can be used for bio-sensing applications owing to their versatile optical properties.

C-reactive Protein Testing Market Report Highlights:

  • The immunoturbidimetric assay generated the largest revenue share amongst all the assay types in 2020 owing to the development and launch of the highly sensitive, automated, and less expensive immunoturbidimetric assay with a broad measuring range for the levels of C-reactive protein in samples
  • hs-CRP was the highest revenue-generating detection range segment in 2020 as it features a broad detection range as compared to conventional CRP
  • Cardiovascular diseases are the most common application of c-reactive protein testing and is anticipated to dominate the market throughout the analysis period
  • This is because of the high adoption rate of c-reactive protein tests to detect inflammation in arteries and thus patients at high risk for heart attack, stroke, peripheral arterial diseases, and other cardiovascular disorders
  • The hospitals segment registered the market share in 2020 owing to the rising penetration of CRP testing in hospitals, especially after the COVID-19 pandemic, and thereby increase in the testing rate
  • North America accounted for the largest market share in 2020. This can be attributed to various factors such as well-established healthcare infrastructure, supportive government policies, and high R&D investments in the region
  • In addition, the rising incidence of chronic heart diseases and cancers is also one of the major factors responsible for market growth
  • The Asia Pacific is projected to grow at the fastest pace. The COVID-19 pandemic was originated in China. Being the potential biomarker for determining the severity of the infection and the rapidly increasing number of COVID-19 cases in Asian countries, the demand for CRP testing is expected to increase in the near future
  • According to an article published in June 2021, doctors are recommending CRP testing for the COVID-19 patients with critical conditions who are in hospital care. This is expected to increase the demand, in turn, driving the market
  • These companies are involved in their business expansion through the launch of novel products and expand their market presence through agreements, partnerships, and other initiatives

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Overview
  • 1.2 Market Segmentation & Scope
  • 1.3 Competitive Insights

Chapter 2 Research Methodology

  • 2.1 Information Procurement
    • 2.1.1 Purchased database:
    • 2.1.2 GVR's internal database
    • 2.1.3 Secondary sources:
    • 2.1.4 Primary research:
    • 2.1.5 Details of primary research
  • 2.2 Information or Data Analysis
    • 2.2.1 Data analysis models
  • 2.3 Market Formulation & Validation
  • 2.4 Model Details
    • 2.4.1 Commodity flow analysis (Model 1)
      • 2.4.1.1 Approach 1: Commodity flow approach
    • 2.4.2 Volume price analysis (Model 2)
      • 2.4.2.1 Approach 2: Volume price analysis
  • 2.5 List of Secondary Sources
  • 2.6 List of Primary Sources
  • 2.7 Objectives
    • 2.7.1 Objective 1
    • 2.7.2 Objective 2

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Increasing R&D in the field of C-reactive protein testing
      • 3.1.1.2 Rising incidence of chronic disorders
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Availability of alternative disease testing methods
  • 3.2 Opportunity Analysis
    • 3.2.1 Technological advancements pertaining to conventional CRP tests
    • 3.2.2 Growing adoption of point-of-care tests
  • 3.3 Threat Analysis
    • 3.3.1 Threat analysis on conventional CRP tests
  • 3.4 Penetration & Growth Prospect Mapping for Assay Type, 2020
  • 3.5 C-reactive Protein (CRP) Testing Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.6 IndustryAnalysis - Porter's
  • 3.7 Impact of COVID-19 Pandemic on Market

Chapter 4 C-reactive Protein (CRP) Testing Market: Assay Type Estimates & Trend Analysis

  • 4.1 C-Reactive Protein Testing Market: Assay Type Movement Analysis
  • 4.2 Immunoturbidimetric Assay
    • 4.2.1 Global immunoturbidimetric assay market, 2017 - 2028 (USD Million)
  • 4.3 ELISA
    • 4.3.1 Global ELISA market, 2017 - 2028 (USD Million)
    • 4.3.2 Clinical ELISA
      • 4.3.2.1 Global clinical ELISA market, 2017 - 2028 (USD Million)
    • 4.3.3 Nonclinical ELISA
      • 4.3.3.1 Global nonclinical ELISA market, 2017 - 2028 (USD Million)
  • 4.4 Chemiluminescence Immunoassay
    • 4.4.1 Global Chemiluminescence Immunoassay market, 2017 - 2028 (USD Million)
  • 4.5 Others
    • 4.5.1 Global other assay types market, 2017 - 2028 (USD Million)

Chapter 5 C-reactive Protein (CRP) Testing Market: Detection Range Estimates & Trend Analysis

  • 5.1 C-Reactive Protein Testing Market: Detection Range Movement Analysis
  • 5.2 High Sensitivity C-reactive Protein (hs-CRP)
    • 5.2.1 Global hs-CRP market, 2017 - 2028 (USD Million)
  • 5.3 Conventional CRP
    • 5.3.1 Global conventional CRP market, 2017 - 2028 (USD Million)
  • 5.4 Cardiac CRP (cCRP)
    • 5.4.1 Global cCRP market, 2017 - 2028 (USD Million)

Chapter 6 C-reactive Protein (CRP) Testing Market: Disease Area Estimates & Trend Analysis

  • 6.1 C-Reactive Protein Testing Market: Disease Area Movement Analysis
  • 6.2 Cardiovascular Diseases
    • 6.2.1 Global cardiovascular diseases CRP tests market, 2017 - 2028 (USD Million)
  • 6.3 Cancer
    • 6.3.1 Global cancer CRP tests market, 2017 - 2028 (USD Million)
  • 6.4 Rheumatoid Arthritis
    • 6.4.1 Global rheumatoid arthritis CRP tests market, 2017 - 2028 (USD Million)
  • 6.5 Inflammatory Bowel Disease
    • 6.5.1 Global inflammatory bowel disease CRP tests market, 2017 - 2028 (USD Million)
  • 6.6 Endometriosis
    • 6.6.1 Global endometriosis CRP tests market, 2017 - 2028 (USD Million)
  • 6.7 Lupus
    • 6.7.1 Global lupus CRP tests market, 2017 - 2028 (USD Million)
  • 6.8 Others
    • 6.8.1 Global others market, 2017 - 2028 (USD Million)

Chapter 7 C-reactive Protein (CRP) Testing Market: End-use Estimates & Trend Analysis

  • 7.1 C-Reactive Protein Testing Market: End-use Movement Analysis
  • 7.2 Clinics
    • 7.2.1 Global clinics market, 2017 - 2028 (USD Million)
    • 7.2.2 Clinics, by entity
      • 7.2.2.1 Physician offices
      • 7.2.2.1.1 Global physician offices market, 2017 - 2028 (USD Million)
      • 7.2.2.2 Small clinics
      • 7.2.2.2.1 Global small clinics market, 2017 - 2028 (USD Million)
      • 7.2.2.3 Others
      • 7.2.2.3.1 Global other clinics market, 2017 - 2028 (USD Million)
    • 7.2.3 Clinics, by setting
      • 7.2.3.1 Urban setting
      • 7.2.3.1.1 Global urban setting clinics market, 2017 - 2028 (USD Million)
      • 7.2.3.2 Rural settings
      • 7.2.3.2.1 Global rural settings clinic market, 2017 - 2028 (USD Million)
  • 7.3 Hospitals
    • 7.3.1 Global hospitals market, 2017 - 2028 (USD Million)
    • 7.3.2 Urban setting
      • 7.3.2.1 Global urban setting hospitals market, 2017 - 2028 (USD Million)
    • 7.3.3 Rural setting
      • 7.3.3.1 Global rural setting hospitals market, 2017 - 2028 (USD Million)
  • 7.4 Laboratories
    • 7.4.1 Global laboratories market, 2017 - 2028 (USD Million)
    • 7.4.2 Urban setting
      • 7.4.2.1 Global urban setting laboratories market, 2017 - 2028 (USD Million)
    • 7.4.3 Rural setting
      • 7.4.3.1 Global rural setting laboratories market, 2017 - 2028 (USD Million)
  • 7.5 Assisted Living Healthcare Facilities
    • 7.5.1 Global assisted living healthcare facilities market, 2017 - 2028 (USD Million)
    • 7.5.2 Urban setting
      • 7.5.2.1 Global urban setting assisted living healthcare facilities market, 2017 - 2028 (USD Million)
    • 7.5.3 Rural setting
      • 7.5.3.1 Global rural setting assisted living healthcare facilities market, 2017 - 2028 (USD Million)
  • 7.6 Home
    • 7.6.1 Global home market, 2017 - 2028 (USD Million)
  • 7.7 Others
    • 7.7.1 Global others market, 2017 - 2028 (USD Million)

Chapter 8 C-reactive Protein (CRP) Testing Market: Regional Estimates & Trend Analysis by Assay, Detection Area, Disease Area, & End-use

  • 8.1 C-Reactive Protein Testing Market Share by Region, 2020 & 2028
  • 8.2 North America
    • 8.2.1 North America C-reactive protein testing market, 2017 - 2028 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
      • 8.2.2.2 U.S. C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
      • 8.2.2.3 U.S. C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
      • 8.2.2.4 U.S. C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
      • 8.2.3.2 Canada C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
      • 8.2.3.3 Canada C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
      • 8.2.3.4 Canada C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe C-reactive protein testing market, 2017 - 2028 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
      • 8.3.2.2 Germany C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
      • 8.3.2.3 Germany C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
      • 8.3.2.4 Germany C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 U.K. C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
      • 8.3.3.2 U.K. C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
      • 8.3.3.3 U.K. C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
      • 8.3.3.4 U.K. C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific C-reactive protein testing market, 2017 - 2028 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
      • 8.4.2.2 Japan C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
      • 8.4.2.3 Japan C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
      • 8.4.2.4 Japan C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
      • 8.4.3.2 China C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
      • 8.4.3.3 China C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
      • 8.4.3.4 China C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America C-reactive protein testing market, 2017 - 2028 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
      • 8.5.2.2 Brazil C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
      • 8.5.2.3 Brazil C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
      • 8.5.2.4 Brazil C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 Middle East & Africa C-reactive protein testing market, 2017 - 2028 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa C-reactive protein testing market, by assay type, 2017 - 2028 (USD Million)
      • 8.6.2.2 South Africa C-reactive protein testing market, by detection range, 2017 - 2028 (USD Million)
      • 8.6.2.3 South Africa C-reactive protein testing market, by disease area, 2017 - 2028 (USD Million)
      • 8.4.2.4 South Africa C-reactive protein testing market, by end use, 2017 - 2028 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Recent Developments & Impact Analysis, by Key Market Participants
  • 9.3 Public Companies
    • 9.3.1 Company market position analysis
  • 9.4 Private Companies
    • 9.4.1 List of key emerging companies
  • 9.5 Strategy Framework
  • 9.6 Company Profiles
    • 9.6.1 Thermo Fisher Scientific, Inc.
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial performance
      • 9.6.1.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.2 F. Hoffmann-La Roche Ltd.
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 Danaher
      • 9.6.3.1 Company overview
      • 9.6.3.1.1 Beckman Coulter, Inc.
      • 9.6.3.1.2 Radiometer
      • 9.6.3.2 Financial performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 Quest Diagnostics Incorporated
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 Siemens
      • 9.6.5.1 Company overview
      • 9.6.5.2 Financial performance
      • 9.6.5.3 Product benchmarking
      • 9.6.5.4 Strategic initiatives
    • 9.6.6 Abbott Laboratories
      • 9.6.5.1 Company overview
      • 9.6.6.1.1 Alere Inc.
      • 9.6.6.2 Financial performance
      • 9.6.6.3 Product benchmarking
      • 9.6.6.4 Strategic initiatives
    • 9.6.7 Laboratory Corporation of America Holdings (LabCorp)
      • 9.6.7.1 Company overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product benchmarking
      • 9.6.7.4 Strategic initiatives
    • 9.6.8 Merck KGaA
      • 9.6.8.1 Company overview
      • 9.6.8.1.1 Sigma-Aldrich Co. LLC
      • 9.6.8.1.2 Merck Millipore
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product benchmarking
      • 9.6.8.4 Strategic initiatives
    • 9.6.9 Abaxis, Inc.
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 Ortho Clinical Diagnostics
      • 9.6.10.1 Company overview
      • 9.6.10.2 Financial performance
      • 9.6.10.3 Product benchmarking
      • 9.6.10.4 Strategic initiatives
    • 9.6.11 Getein Biotech, Inc.
      • 9.6.11.1 Company overview
      • 9.6.11.2 Financial performance
      • 9.6.11.3 Product benchmarking
    • 9.6.12 HORIBA, Ltd.
      • 9.6.12.1 Company overview
      • 9.6.12.2 Financial performance
      • 9.6.12.3 Product benchmarking
      • 9.6.12.4 Strategic initiatives
    • 9.6.13 RandoxLaboratories Ltd.
      • 9.6.13.1 Company overview
      • 9.6.13.2 Financial performance
      • 9.6.13.3 Product benchmarking
      • 9.6.13.4 Strategic initiatives
    • 9.6.14 BODITECH MED, INC
      • 9.6.14.1 Company overview
      • 9.6.14.2 Financial performance
      • 9.6.14.3 Product benchmarking
      • 9.6.14.4 Strategic initiatives
    • 9.6.15 Aidian
      • 9.6.15.1 Company overview
      • 9.6.15.2 Financial performance
      • 9.6.15.3 Product benchmarking
      • 9.6.15.4 Strategic initiatives
    • 9.6.16 EurolyserDiagnostica GmbH
      • 9.6.16.1 Company overview
      • 9.6.16.2 Financial performance
      • 9.6.16.3 Product benchmarking
      • 9.6.16.4 Strategic initiatives
    • 9.6.17 Abcam plc
      • 9.6.17.1 Company overview
      • 9.6.17.2 Financial performance
      • 9.6.17.3 Product benchmarking
      • 9.6.17.4 Strategic initiatives
    • 9.6.18 Bio-Techne
      • 9.6.18.1 Company overview
      • 9.6.18.2 Financial performance
      • 9.6.18.3 Product benchmarking
      • 9.6.18.4 Strategic initiatives
    • 9.6.19 EKF Diagnostics
      • 9.6.19.1 Company overview
      • 9.6.19.2 Financial performance
      • 9.6.19.3 Product benchmarking
      • 9.6.19.4 Strategic initiatives
    • 9.6.20 SD Biosensor, INC.
      • 9.6.20.1 Company overview
      • 9.6.20.2 Financial performance
      • 9.6.20.3 Product benchmarking
      • 9.6.20.4 Strategic initiatives